Research ArticleAccepted Article
Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study
Pavlos Stamatis, Carl Turesson, Minna Willim, Jan-Åke Nilsson, Martin Englund and Aladdin J. Mohammad
The Journal of Rheumatology June 2019, jrheum.190236; DOI: https://doi.org/10.3899/jrheum.190236
Pavlos Stamatis
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Carl Turesson
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Minna Willim
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Jan-Åke Nilsson
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Martin Englund
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Aladdin J. Mohammad
Lund University, Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden; Lund University, Department of Clinical Sciences Malmö, Section of Rheumatology, Malmö, Sweden; und University, Department of Clinical Sciences Lund, Orthopaedics and Clinical Epidemiology Unit, Lund, Sweden; Department of Medicine, University of Cambridge, Cambridge, UK. This study was supported by grants from the Swedish Rheumatism Association (Reumatikerförbundet R-551641) and The Swedish Medical Association (Läkarsällskapet SLS-783621). Address correspondence to Pavlos Stamatis, MD Department of Rheumatology, Skåne University Hospital, Lund SE-221 85 Lund, Sweden. E-mail: pavlos.stamatis@med.lu.se
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study
Pavlos Stamatis, Carl Turesson, Minna Willim, Jan-Åke Nilsson, Martin Englund, Aladdin J. Mohammad
The Journal of Rheumatology Jun 2019, jrheum.190236; DOI: 10.3899/jrheum.190236